Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$1.64 - $2.35 $44,936 - $64,390
-27,400 Reduced 2.68%
993,380 $1.74 Million
Q4 2022

Feb 14, 2023

SELL
$1.73 - $3.77 $422,358 - $920,400
-244,138 Reduced 19.3%
1,020,780 $2.52 Million
Q3 2022

Nov 14, 2022

SELL
$3.53 - $6.9 $73,116 - $142,919
-20,713 Reduced 1.61%
1,264,918 $4.63 Million
Q1 2022

May 13, 2022

BUY
$7.08 - $8.88 $411,857 - $516,567
58,172 Added 4.74%
1,285,631 $11.2 Million
Q4 2021

Feb 15, 2022

BUY
$7.09 - $8.7 $420,195 - $515,614
59,266 Added 5.07%
1,227,459 $9.45 Million
Q3 2021

Nov 12, 2021

BUY
$7.4 - $10.2 $862,174 - $1.19 Million
116,510 Added 11.08%
1,168,193 $9.42 Million
Q2 2021

Aug 12, 2021

BUY
$8.25 - $11.62 $305,250 - $429,940
37,000 Added 3.65%
1,051,683 $10.7 Million
Q1 2021

May 10, 2021

BUY
$7.08 - $10.03 $7.18 Million - $10.2 Million
1,014,683 New
1,014,683 $9.16 Million

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $160M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.